Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells

Oncogene

Volumn 23, Issue 17, 2004, Pages 3024-3032

  Ro, Torstein Baade ^a   Holt, Randi Utne ^a   Brenne, Anne Tove ^a   Hjorth Hansen, Henrik ^b   Waage, Anders ^a   Hjertner, Oyvind ^b   Sundan, Anders ^a   Borset, Magne ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Apoptosis; BMP 5; BMP 6; BMP 7; Myeloma

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR; FOLLISTATIN; NOGGIN; OSTEOGENIC PROTEIN 1; PROTEIN ALK 2; PROTEIN ALK 3; PROTEIN ALK 6; RECEPTOR PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MULTIPLE MYELOMA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 2442625301     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207386     Document Type: Article

References (36)

1. Beck HN, Drahushuk K, Jacoby DB, Higgins D and Lein PJ. (2001). BMC Neurosci., 2, 12.
2. Bhatia M, Bonnet D, Wu D, Murdoch B, Wrana J, Gallacher L and Dick JE. (1999). J. Exp. Med., 189, 1139-1148.
3. Borset M, Hjorth-Hansen H, Seidel C, Sundan A and Waage A. (1996). Blood, 88, 3998-4004.
4. Borset M, Waage A, Brekke OL and Helseth E. (1994). Eur. J. Haematol., 53, 31-37.
5. Brenne AT, Ro TB, Waage A, Sundan A, Borset M and Hjorth-Hansen H. (2002). Blood, 99, 3756-3762.
6. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P, Chen HL, Hoffer BJ and Wang Y. (2003). Stroke, 34, 558-564.
7. Durie BG and Salmon SE. (1975). Cancer, 36, 842-854.
8. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K and Imamura T. (1999). J. Cell Sci., 112 (Part 20), 3519-3527.
9. Franzen A and Heldin NE. (2001). Biochem. Biophys. Res. Commun., 285, 773-781.
10. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ and Yin S. (2001). J. Bone Joint Surg. Am., 83-A (Suppl 1), S151-S158.
11. Gazitt Y. (1999). Leukemia, 13, 1817-1824.
12. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI and Knaus P. (2000). Mol. Biol. Cell, 11, 1023-1035.
13. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE. (1996). Science, 271, 350-353.
14. Hallahan AR, Pritchard JI, Chandraratna RAS, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ and Olson JM. (2003). Nat. Med., 9, 1033-1038.
15. Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A and Sundan A. (2001). Blood, 97, 516-522.
16. Jackson N, Lowe J, Ball J, Bromidge E, Ling NR, Larkins S, Griffith MJ and Franklin IM. (1989). Clin. Exp. Immunol., 75, 93-99.
17. Jernberg-Wiklund H, Pettersson M and Nilsson K. (1991). Eur. J. Haematol., 46, 231-239.
18. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T and Ikeda Y. (2000). Blood, 96, 2005-2011.
19. Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK and Morton RA. (2000). Cancer Res., 60, 2840-2844.
20. Nishihara T, Okahashi N and Ueda N. (1993). Biochem. Biophys. Res. Commun., 197, 985-991.
21. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI and Knaus P. (2002). J. Biol. Chem., 277, 5330-5338.
22. Paine-Saunders S, Viviano BL, Economides AN and Saunders S. (2002). J. Biol. Chem., 277, 2089-2096.
23. Rodriguez-Leon J, Merino R, Macias D, Ganan Y, Santesteban E and Hurle JM. (1999). Nat. Cell Biol., 1, 125-126.
24. Seidel C, Sundan A, Hjorth M, Turesson I, Dahl IM, Abildgaard N, Waage A and Borset M. (2000). Blood, 95, 388-392.
25. Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K and Kishimoto T. (1995). Blood, 85, 757-764.
26. Tarte K, Zhan F, De Vos J, Klein B and Shaughnessy J. (2003). Blood, 102, 592-600.
27. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K and Heldin CH. (1994a). Science, 264, 101-104.
28. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH and Miyazono K. (1994b). J. Biol. Chem., 269, 16985-16988.
29. Tsuchida K, Sawchenko PE, Nishikawa S and Vale WW. (1996). Mol. Cell Neurosci., 7, 467-478.
30. Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL and Anderson KC. (1996). Blood, 87, 1928-1938.
31. Urist MR. (1965). Science, 150, 893-899.
32. Wach S, Schirmacher P, Protschka M and Blessing M. (2001). Oncogene, 20, 7761-7769.
33. Wozney JM. (1989). Prog. Growth Factor Res., 1, 267-280.
34. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH and Miyazono K. (1995). J. Cell Biol., 130, 217-226.
35. Zavadil J, Brezinova J, Svoboda P, Zemanova Z and Michalova K. (1997). Leukemia, 11, 1187-1192.
36. Zimmerman LB, Jesus-Escobar JM and Harland RM. (1996). Cell, 86, 599-606.